Barron's has devoted an article to Barclays Capital's leveraged ETFs that made their debut last week.
Marketed under the iPath banner, the products
remove leverage targets tied to daily, weekly or even monthly index returns, the article notes.
The funds start with either 200 percent or 300 percent of leveraged positions but the leverage will fluctuate with the market, rather than resetting to each day's index close.
"It's probably too strong to say that these new funds solve all of the problems with holding leveraged ETFs for more than a relatively short period of time," Morningstar analyst Timothy
Strauts tells the pub. "But they're an ingenious idea that can mitigate a lot of risk." 
Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE